Business Summary
|
Calypte Biomedical Corporation develops, manufactures, and distributes in vitro diagnostic tests, primarily for the diagnosis of human immunodeficiency virus (HIV) infection. The Company is focused on the development and commercialization of its Aware HIV-1/2 rapid tests. During the year ended December 31, 2008, the Company introduced Aware Messenger, its oral fluid sample collection device. During 2008, the Company launched a range of life sciences products, including Aware Messenger, as well as a number of recombinant proteins and specialty assay reagents, which it marketed through a Web-portal at www.calyptelifesciences.com. During 2008, it suspended marketing and sales of its life sciences products.
| | (Source: 10-K)
|
|
|
